Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chai Ge Antipyretic Oral Solution for Upper Respiratory Tract Infection (Wind-heat Cold)
CTR20170781Phase 2Completed
- Sponsor
- Yuzhihua Pharmaceutical
- Start
- Sep 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Chai Ge Antipyretic Oral Solution in upper respiratory infection (URI), sponsored by Yuzhihua Pharmaceutical. Started Sep 2017; status: completed.
02
Drugs
Chai Ge Antipyretic Oral Solution
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20170781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170781.